Close Menu

NEW YORK – A federal judge has narrowed a patent infringement lawsuit filed by Fluidigm by dismissing some of the firm's claims against competitor IonPath. Fluidigm's allegations of direct infringement remain, however, and the court did leave open the possibility for the firm to file an amended complaint to address the deficiencies in the case.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.